What is the recommended dose of sodium bicarbonate (NaHCO3) for treating metabolic acidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Calculating Sodium Bicarbonate Dose in Metabolic Acidosis

For severe metabolic acidosis (pH <7.1), administer 1-2 mEq/kg IV (typically 50-100 mEq or 50-100 mL of 8.4% solution) given slowly over several minutes, with repeat dosing guided by arterial blood gas analysis targeting a pH of 7.2-7.3, not complete normalization. 1

Initial Dosing Algorithm

Standard Adult Dosing

  • Administer an initial bolus of 1-2 mEq/kg IV (typically 50-100 mEq or 50-100 mL of 8.4% solution) for severe metabolic acidosis with pH <7.1 and base excess <-10 1, 2
  • Give the dose slowly over several minutes to minimize complications from hypertonic solution 1, 2
  • In cardiac arrest, a rapid dose of 44.6-100 mEq (one to two 50 mL vials) may be given initially, continued at 44.6-50 mEq every 5-10 minutes as indicated by arterial pH monitoring 1, 2

Pediatric Dosing

  • Children require 1-2 mEq/kg IV administered slowly 1, 3
  • Infants under 2 years must receive only 0.5 mEq/mL (4.2%) concentration, achieved by diluting 8.4% solution 1:1 with normal saline or sterile water 1
  • Children ≥2 years may use 8.4% solution, though dilution is often performed for safety 1

Calculating Bicarbonate Deficit

Practical Formula for Bedside Calculation

  • Use the formula: Bicarbonate deficit (mEq) = 0.5 × body weight (kg) × (desired HCO3⁻ - actual HCO3⁻) 4
  • Target a desired bicarbonate of approximately 15-18 mEq/L initially, which typically achieves a pH around 7.30 4
  • This formula is designed to elevate pH to approximately 7.30, not to complete normalization, reducing risk of overtitration 4

Alternative Dosing Approach

  • For less urgent metabolic acidosis, administer 2-5 mEq/kg body weight over 4-8 hours depending on severity 1, 2
  • This produces measurable improvement in acid-base status while allowing time for physiologic adjustment 1, 2

Critical Indications and Contraindications

When to Give Bicarbonate

  • Severe metabolic acidosis with pH <7.1 AND base excess <-10 1
  • Life-threatening hyperkalemia (as temporizing measure while definitive therapy initiated) 1
  • Tricyclic antidepressant or sodium channel blocker overdose with QRS prolongation >120 ms 1
  • Diabetic ketoacidosis ONLY if pH <6.9 1

When NOT to Give Bicarbonate

  • Do not give bicarbonate for hypoperfusion-induced lactic acidemia when pH ≥7.15 1, 5
  • Multiple blinded randomized trials show no difference in hemodynamic variables or vasopressor requirements compared to equimolar saline 1, 5
  • Do not use for tissue hypoperfusion-related acidosis as routine therapy 1
  • Diabetic ketoacidosis with pH ≥7.0 does not benefit from bicarbonate 1

Continuous Infusion Dosing

For Ongoing Alkalinization

  • After initial bolus, continue with infusion of 150 mEq/L solution at 1-3 mL/kg/hour if ongoing alkalinization needed 1
  • For sodium channel blocker toxicity, give bolus of 50-150 mEq followed by continuous infusion of 150 mEq/L solution at 1-3 mL/kg/hour 1

Specific DKA Protocol

  • For pH <6.9: infuse 100 mmol sodium bicarbonate in 400 mL sterile water at 200 mL/hour 1
  • For pH 6.9-7.0: infuse 50 mmol sodium bicarbonate in 200 mL sterile water at 200 mL/hour 1

Monitoring Requirements During Therapy

Essential Parameters to Track

  • Measure arterial blood gases every 2-4 hours to assess pH, PaCO2, and bicarbonate response 1
  • Monitor serum electrolytes every 2-4 hours, including sodium (target <150-155 mEq/L), potassium, and ionized calcium 1
  • Target pH of 7.2-7.3, avoiding pH >7.50-7.55 1

Repeat Dosing Strategy

  • Further bicarbonate administration depends on clinical response and repeat arterial blood gas analysis 1, 2
  • Do not attempt full correction of low total CO2 content during first 24 hours, as this may cause unrecognized alkalosis due to delayed ventilatory readjustment 2
  • Achievement of total CO2 content of about 20 mEq/L at end of first day typically associates with normal blood pH 2

Critical Safety Considerations

Adverse Effects to Monitor

  • Sodium and fluid overload from hypertonic solution 1, 5
  • Increased PCO2 requiring adequate ventilation to clear excess CO2 1, 5
  • Decreased ionized calcium (0.95 to 0.87 mmol/L), affecting cardiac contractility 1, 5
  • Hypokalemia from intracellular potassium shift requiring replacement 1
  • Paradoxical intracellular acidosis if given without adequate ventilation 1

Administration Precautions

  • Never mix sodium bicarbonate with calcium-containing solutions or vasoactive amines (causes precipitation or inactivation) 1
  • Flush IV line with normal saline before and after bicarbonate administration 1
  • Ensure effective ventilation is established before giving bicarbonate, as it produces CO2 that must be eliminated 1

Common Clinical Pitfalls

Errors to Avoid

  • Giving bicarbonate for lactic acidosis with pH ≥7.15 provides no hemodynamic benefit and may cause harm 1, 5
  • Attempting complete pH normalization in first 24 hours risks severe alkalosis 2
  • Ignoring the underlying cause—bicarbonate buys time but does not treat the disease 1
  • Using bicarbonate without ensuring adequate ventilation causes paradoxical worsening of intracellular acidosis 1
  • Failing to monitor ionized calcium, especially with doses >50-100 mEq 1, 5

Special Population Considerations

  • In vasopressor-dependent patients with metabolic acidosis, early bicarbonate may improve mean arterial pressure at 6 hours and potentially reduce ICU mortality 6
  • Chronic kidney disease patients require oral sodium bicarbonate 2-4 g/day (25-50 mEq/day) to maintain serum bicarbonate ≥22 mmol/L 1, 7
  • Newborns require only 4.2% concentration with maximum rate of 8 mEq/kg/day 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.